Live Chat

Negocie Bristol Myers BMY

Venda
 Comprar

Gráfico BristolMyers ao vivo

5m 15m 30m 1h 4h 1d 1w

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

Info

Spread

0.33

Spread (%)

0.6221 %

Alavancagem

1:10

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Segunda-feira

13:31 - 19:59

Terça-feira

13:31-19:59

Quarta-feira

13:31-19:59

Quinta-feira

13:31-19:59

Sexta-feira

13:31-19:59

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

113476673536

Ações em circulação

2028179968

Data dos rendimentos (Próxima)

2001-08-07

Rendim Divid

2024-11-01

Data Ex-Dividendos

2024-10-04

Taxa anual futura de dividendos

2.4

Rendimento anual futuro de dividendos

0.0433

EPS

-3.61

Saiba mais sobre este instrumento

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):

Negociar agora

Negociar agora

Negociar agora

Negociar agora
Instrumentos relacionados

Últimas notícias

Fique em dia com as últimas notícias financeiras pelo mundo afora.

Quarta-feira, 6 Novembro 2024

U.S. presidential election market volatility drives Bitcoin prices to reach a historic high

Stock market rally

Terça-feira, 5 Novembro 2024

US Election Results Trigger Stock Gains Across Europe, Asia, and US

US Election Trump's victory

Terça-feira, 5 Novembro 2024

Trump Victory Spurs Market Gains and Economic Shift Expectations

Terça-feira, 5 Novembro 2024

US election: bitcoin price (BTC) surged to new record as Trump leading ahead

Terça-feira, 5 Novembro 2024

Stock Market Today: Wall Street Rallies on Election Day Amid Strong Economic Outlook

US Election 2024 Trump

Terça-feira, 5 Novembro 2024

Early Election Results Shift Markets as Trump’s Chances Rise

Segunda-feira, 4 Novembro 2024

Stock Market Today: S&P 500 Declines as Investors Brace for US Election

Segunda-feira, 4 Novembro 2024

US election: What will happen to tesla stock if Trump wins?

Ver todas as notícias
Trustpilot
Live Chat